ArticleScientific reports2026

Deciphering glutamine metabolic reprogramming: a novel therapeutic target ALDH18A1 in triple-negative breast cancer.

Shuixian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.